Validation of Interobserver Agreement in Lung Cancer Assessment: Hematoxylin-Eosin Diagnostic Reproducibility for Non–Small Cell Lung Cancer: The 2004 World Health Organization Classification and Therapeutically Relevant Subsets

CONTEXT: Precise subtype diagnosis of non–small cell lung carcinoma is increasingly relevant, based on the availability of subtype-specific therapies, such as bevacizumab and pemetrexed, and based on the subtype-specific prevalence of activating epidermal growth factor receptor mutations. OBJECTIVES...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Arch Pathol Lab Med
Main Authors: Grilley-Olson, Juneko E., Hayes, D. Neil, Moore, Dominic T., Leslie, Kevin O., Wilkerson, Matthew D., Qaqish, Bahjat F., Hayward, Michele C., Cabanski, Christopher R., Yin, Xiaoying, Socinski, Mark A., Stinchcombe, Thomas E., Thorne, Leigh B., Allen, Timothy Craig, Banks, Peter M., Beasley, Mary B., Borczuk, Alain C., Cagle, Philip T., Christensen, Rebecca, Colby, Thomas V., Deblois, Georgean G., Elmberger, Göran, Graziano, Paolo, Hart, Craig F., Jones, Kirk D., Maia, Diane M., Miller, C. Ryan, Nance, Keith V., Travis, William D., Funkhouser, William K.
Formato: Artigo
Idioma:Inglês
Publicado em: 2012
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5787023/
https://ncbi.nlm.nih.gov/pubmed/22583114
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5858/arpa.2012-0033-OA
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados